Madrigal Pharmaceuticals (YDO1) Ownership - Who Owns Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals (YDO1) Ownership Overview
- 18.08% Insiders
- 24.34% Mutual Funds
- 0.72% Other Institutional Investors
- 12.81% ETFs
- 44.05% Public Companies and Individual Investors
The ownership structure of Madrigal Pharmaceuticals (DE:YDO1) stock is a mix of institutional, retail, and individual investors. Approximately 37.87% of the company’s stock is owned by Institutional Investors, 18.08% is owned by Insiders, and 44.05% is owned by Public Companies and Individual Investors.
The ownership structure of Madrigal Pharmaceuticals (DE:YDO1) stock is a mix of institutional, retail, and individual investors. Approximately 37.87% of the company’s stock is owned by Institutional Investors, 18.08% is owned by Insiders, and 44.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 10, 2026 | William John Sibold | $3,407,371 | |
| Aug 19, 2026 | Shannon T Kelley | $341,940 | |
| May 17, 2026 | David Soergel | $435,420 | |
| Mar 05, 2026 | William John Sibold | $718,316 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €618,445 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | €11,191,410 | |
| Dec 31, 2025 | Gilder Gagnon Howe & Co Llc. | €19,489,755 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | €65,027,578 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Felix Baker | 2,143,131 | Institution | 9.28% | 925,067,494 |
| Baker Bros. Advisors Lp | 1,948,876 | Insider | 8.44% | 841,218,683 |
| Vanguard | 1,560,151 | Institution | 6.75% | 673,428,258 |
| Vanguard Index Funds | 1,468,704 | Institution | 6.36% | 633,955,801 |
| John Paulson | 1,340,020 | Institution | 5.80% | 578,410,253 |
| Rebecca Taub | 1,108,207 | Insider | 4.80% | 478,349,794 |
| Janus Investment Fund | 1,023,473 | Institution | 4.43% | 441,774,956 |
| Paul A. Friedman | 842,704 | Insider | 3.65% | 363,747,283 |
| Ishares | 568,026 | Institution | 2.46% | 245,184,447 |
| Vanguard Specialized Funds | 563,117 | Institution | 2.44% | 243,065,511 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,468,704 | Institution | 6.36% | 633,955,801 |
| Janus Investment Fund | 1,023,473 | Institution | 4.43% | 441,774,956 |
| Vanguard Specialized Funds | 563,117 | Institution | 2.44% | 243,065,511 |
| Fidelity Concord Street Trust | 198,002 | Institution | 0.86% | 85,466,177 |
| Columbia Funds Series Trust I | 191,293 | Institution | 0.83% | 82,570,284 |
| Vanguard Explorer Fund | 190,140 | Institution | 0.82% | 82,072,600 |
| Lord Abbett Securities Trust | 144,625 | Institution | 0.63% | 62,426,369 |
| Fidelity Salem Street Trust | 114,814 | Institution | 0.50% | 49,558,659 |
| Fidelity Select Portfolios | 98,095 | Institution | 0.42% | 42,342,020 |
| Manager Directed Portfolios | 86,744 | Institution | 0.38% | 37,442,440 |
FAQ
Who Owns Madrigal Pharmaceuticals (DE:YDO1)?
According to the latest TipRanks data, approximately 37.87% of the company's stock is held by institutional investors, 18.08% is held by insiders, and 44.05% is held by public companies and individual investors.
What percentage of Madrigal Pharmaceuticals (DE:YDO1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.87% of Madrigal Pharmaceuticals (DE:YDO1) stock is held by institutional investors: 24.34% by mutual funds, 12.81% by ETFs and 0.72% by other institutional investors.
What percentage of Madrigal Pharmaceuticals (DE:YDO1) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.05% of Madrigal Pharmaceuticals (DE:YDO1) stock is held by public companies and individual investors.
Who owns the most shares of Madrigal Pharmaceuticals (DE:YDO1)?
Felix Baker owns the most shares of Madrigal Pharmaceuticals (DE:YDO1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.